The New England journal of medicine
-
Autoimmune polyendocrine syndrome type 1 (APS-1) is a life-threatening, autosomal recessive syndrome caused by autoimmune regulator (AIRE) deficiency. In APS-1, self-reactive T cells escape thymic negative selection, infiltrate organs, and drive autoimmune injury. The effector mechanisms governing T-cell-mediated damage in APS-1 remain poorly understood. ⋯ Our findings indicate that APS-1, which is caused by AIRE deficiency, is characterized by excessive, multiorgan interferon-γ-mediated responses. JAK inhibition with ruxolitinib in five patients showed promising results. (Funded by the National Institute of Allergy and Infectious Diseases and others.).
-
Editorial Historical Article
Sixty Years of Hemodynamic Pharmacology in Obstructive Hypertrophic Cardiomyopathy.
-
Comment Letter Comparative Study
Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis. Reply.